Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis

Autor: Sinnecker T., Clarke M. A., Meier D., Enzinger C., Calabrese M., De Stefano N., Pitiot A., Giorgio A., Schoonheim M. M., Paul F., Pawlak M. A., Schmidt R., Kappos L., Montalban X., Rovira A., Evangelou N., Wuerfel J., MAGNIMS Study Group, Filippi M, Rocca M. A.

Publikováno v: Sinnecker, T, Clarke, M A, Meier, D, Enzinger, C, Calabrese, M, De Stefano, N, Pitiot, A, Giorgio, A, Schoonheim, M M, Paul, F, Pawlak, M A, Schmidt, R, Kappos, L, Montalban, X, Rovira, À, Evangelou, N, Wuerfel, J & MAGNIMS Study Group 2019, ' Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis ', JAMA Neurology, vol. 76, no. 12, pp. 1446-1456 . https://doi.org/10.1001/jamaneurol.2019.2478
JAMA Neurology, 76(12), 1446-1456. American Medical Association
JAMA Neurol

Importance: The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI) studies. The diagnostic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef62caa006f1e0a6a46933d724df659
https://research.vumc.nl/en/publications/f290d32a-98d4-4fc0-8898-960ed0bba8b2